Skip to main content
Fig. 2 | BMC Infectious Diseases

Fig. 2

From: Simultaneous 18F-FDG PET/MRI in tuberculous spondylitis: an independent method for assessing therapeutic response - case series

Fig. 2

The second patient’s PET/MRI at 11.5-month anti-TB medication therapy (b) also revealed the decreased bone marrow edema with fatty change, pre- and intra-vertebral abscesses, and SUVmax (from 7.88 of PET/MRI at diagnosis to 4.14) on C1–2 compared with PET/MRI at diagnosis (a). However, positive AFB was detected from the granulation tissue of the surgical field, which resulted in additional anti-TB medication therapy

Back to article page